Investors in Health

Giant Ventures is committed to backing purpose-driven founders who are building companies that make a meaningful impact. They focus on supporting entrepreneurs whose innovations address significant societal or environmental challenges. By providing strategic investment and guidance, Giant Ventures empowers visionary founders to scale their companies and drive positive change in their respective fields. With a mission to foster innovation and sustainability, Giant Ventures seeks to contribute to a future where businesses not only succeed financially but also create lasting value for society and the planet.

Neo Kuma Ventures specializes in investing in early-stage psychedelic healthcare companies that are pioneering clinical research into conditions such as depression, PTSD, addiction, inflammation, and chronic pain. By partnering with leading firms in this emerging field, Neo Kuma Ventures aims to advance and redefine the standard of patient care. Their focus on psychedelic therapies underscores their commitment to supporting innovations that address significant mental health challenges through rigorous scientific research and therapeutic advancements.

Highgoal Capital Management is a technology-focused investment firm known for its expertise in identifying and supporting successful founders and companies across Europe, the Middle East, and Africa. With offices in London, UK, and Tallinn, Estonia, Highgoal Capital is registered with the Estonian Financial Supervision Authority as a small alternative fund manager (Reg. 14982716). The firm is dedicated to backing visionary entrepreneurs on their mission to build globally impactful companies. Highgoal Capital's strategic investments and operational support aim to foster growth and innovation within the technology sector, contributing to the development of sustainable and scalable businesses worldwide.

NV Ventures supports ambitious healthcare and climate technology entrepreneurs throughout their growth and scaling journey. The firm addresses the challenge entrepreneurs face in finding consistent investor support by backing founders across all stages of company development. NV Ventures is stage-agnostic, investing in early to late-stage companies with a focus on Green Energy Transition and Healthcare sectors. Their mission is to foster collaboration among entrepreneurs, investors, engineers, financial sponsors, and other ecosystem stakeholders to maximize collective impact. NV Ventures aims to drive innovation and sustainable growth by connecting diverse expertise and resources, aiming to create synergies that amplify the success of portfolio companies in transformative industries.

Empirical Ventures specializes in supporting innovative approaches to critical problems in biotechnology and life sciences. The firm focuses on investing in companies that are pioneering advancements in healthcare, biotech, and related fields. Empirical Ventures provides strategic capital, industry expertise, and operational support to accelerate the development and commercialization of groundbreaking technologies. Their mission is to drive meaningful impact and transformative change within the biotech and life sciences sectors through targeted investments and partnerships.

Amrock Ventures is dedicated to investing in innovative companies with a long-term vision. The firm focuses on supporting ventures that demonstrate potential for significant growth and impact across various sectors. Amrock Ventures provides strategic capital and operational support to nurture the development and success of innovative ideas and technologies. Their investment approach aims to foster sustainable growth and long-term value creation in the companies they support.

Spex Capital focuses on investing in early-stage digital health ventures aimed at delivering global breakthroughs in healthcare systems. The firm is dedicated to supporting innovative solutions that enhance healthcare delivery through technology and innovation. Spex Capital seeks to empower entrepreneurs and startups in the digital health space, driving transformative changes that improve patient outcomes and efficiency within healthcare systems worldwide.

2xN operates as a venture capital firm specializing in strategic investments and fostering growth in innovative companies. The firm focuses on identifying promising startups and providing them with capital and strategic support to drive their expansion and success. 2xN leverages its expertise and extensive network to empower entrepreneurs and create value in the global market. By partnering with visionary founders, 2xN aims to catalyze innovation and propel startups towards achieving market leadership. For entrepreneurs seeking strategic investment and operational guidance to scale their businesses, 2xN offers a dedicated platform for growth and success.

316VC is a leading investment and advisory firm specializing in early-stage blockchain startups. With a team encompassing expertise in traditional finance, mathematics, PR, and blockchain technology, 316VC provides strategic guidance and accelerates growth. They prioritize maximizing project exposure through strategic partnerships with international PR firms. 316VC invests in innovative projects across DeFi, Web3, NFT Metaverse on Layer 2, Ethereum, Cardano, Solana, and other blockchains, aiming to foster groundbreaking advancements in the blockchain industry globally.

3 Sisters Ventures (3SV), we are a London-based venture capital firm dedicated to investing in tech-enabled solutions that cater to underserved needs among women. We focus on three primary verticals: Health & Self, Work & Wealth, and Family & Crew. Recognizing the historical underfunding of women's needs, we are committed to directing capital towards closing gender gaps in various sectors. Sponsored by IP Group, a FTSE 250 listed investment firm, we are also proud signatories to the Investing in Women Code.

Cornerstone Venture Partners LLP, we are a London-based limited liability partnership registered in England and Wales under number OC440668. Our operations are centered at our registered office located at 10 Orange Street, Haymarket, London, WC2H 7DQ, United Kingdom. We proudly serve as an Appointed Representative of The Fund Incubator Limited, authorized and regulated by the Financial Conduct Authority (FCA) with firm reference number 208716

Rubix Ventures is an investment company dedicated to supporting consumer brands. The firm focuses on identifying and investing in promising consumer-oriented businesses that demonstrate strong growth potential and innovative approaches. Rubix Ventures provides capital, strategic guidance, and operational support to help these brands scale and achieve market leadership. By partnering with entrepreneurial teams, Rubix Ventures aims to foster the growth and success of consumer brands across various sectors, contributing to their expansion and market impact.